Find trials
Search tips

Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes Among Cardiac Patient

Overview

About this study

The purpose of this study is to determine the feasibility of conducting a randomized clinical trial to assess whether an enhanced virtual world-based cardiac rehabilitation (VWCR) program will provide equivalent participation, adherence, and cardiovascular health outcomes to a traditional center-based, in-person cardiac rehab (CR) program. We hypothesize that implementing our patient-centric VWCR program will be feasible at all 3 participating sites and will offer a sufficient alternative to traditional center-based CR (CBCR).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines.
  • Age ≥18 years.
  • Basic Internet navigation skills.
  • Active email address.

Exclusion Criteria: 

  • High risk patients according to the AACVPR risk stratification given safety concern of unsupervised exercise:
    • Patients receiving continuous inotropic support
    • Recent receipt of a mechanical support device
    • Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia)
    • Decompensated heart failure
    • Symptomatic valvular heart disease
    • Uncontrolled angina
    • Pregnancy (due to associated hormonal and weight changes)
    • Receiving continuous inotropic support
    • Presence of a mechanical circulatory support device
    • Decompensated heart failure
    • Symptomatic valvular heart disease
    • Uncontrolled angina
    • Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise
    • Visual/hearing impairment or mental disability that would preclude independent use of the VW platform
    • Non-English-speaking patients due to logistical challenges with real time translation over a virtual platform.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/27/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

LaPrincess Brewer, M.D., M.P.H.

Contact us for the latest status

Contact information:

Lainey Moen M.A.

(507) 266-7062

Moen.Lainey@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Bryan Taylor, Ph.D.

Contact us for the latest status

Contact information:

Jena Hayes M.H.A.

(904) 956-8284

Hayes.Jena@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20585974

Mayo Clinic Footer